RECENT NEWS
Epredia’s digital pathology solution receives US FDA 510(K) clearance
Precision cancer diagnostics firm Epredia has announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx digital pathology solution.
HealthTech Research Centre in In Vitro Diagnostics launched
The NIHR HealthTech Research Centre in In Vitro Diagnostics (HRC IVD) recently launched, bringing together industry, academia, and the healthcare sector to discuss the Centre’s ambitions and priorities.
MHRA appoints new Chief Executive Officer
The government has announced the appointment of Lawrence Tallon as the new Chief Executive Officer at the Medicines and Healthcare products Regulatory Agency (MHRA).
The BSMT 40th Anniversary Microbiology Conference: an early bird opportunity not to miss
Registration is now open for the British Society for Microbial Technology (BSMT) Microbiology Conference, taking place at the RAF Museum in Hendon, North London, on 15 May.
New AI tool for colorectal cancer tissue analysis offers increased accuracy
A new AI-based tool for identifying colorectal cancer from tissue sample analysis has been developed at the University of Jyväskylä, Finland. The new artificial neural network model has surpassed all its predecessors in classification performance.
New digital pathology storage partnership for Fujifilm
Enterprise imaging and informatics firm Fujifilm has announced a new partnership with Tiger Health Technology, a leading provider of hybrid cloud solutions, to optimise data lifecycle management and address key storage-related challenges in digital pathology.
2025 Annual SHOT Symposium
Registrations and abstract submissions for the 2025 Annual SHOT Symposium are now open. Join the Serious Hazards of Transfusion (SHOT) scheme for an engaging and inspiring event, featuring insightful discussions, presentations from expert speakers, key highlights from the latest Annual SHOT Report, and valuable networking opportunities.
New study evaluating home test for type 1 diabetes
A new home test to diagnose type 1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre.
UKHSA warns of potential second norovirus wave
The latest UK Health Security Agency (UKHSA) data shows norovirus cases continue to rise across the country, with laboratory reports at the highest levels since reporting data this way began in 2014. People who have already had the virus this winter could be at risk again, UKHSA is warning, as new data shows a shift in circulating strains.
BIVDA responds to NAO report on AMR targets
In response to the National Audit Office (NAO) report, the British In Vitro Diagnostics Association (BIVDA) calls urgently for improved diagnostic infrastructure and deployment to address antimicrobial resistance (AMR) effectively.
NAO report says 4/5 AMR targets being missed
A National Audit Office report into the Government’s efforts to contain antimicrobial resistance (AMR) has found that only one of the five targets was met or is on track. Resistant infections are still rising as it proves hard to shift the behaviours of millions of citizens and thousands of institutions.
Presymptom Health secures funding to advance rapid infection diagnostics
UK MedTech firm Presymptom Health has secured £200,000 in additional grant funding to speed-up its AI-driven infection detection technology, cutting test times to just 40-60 minutes. Presymptom Health will also use the funding to make its rapid tests compatible with a variety of widely available PCR machines, streamlining diagnostics is secondary care.
Thermo Fisher Scientific acquires Solventum’s Purification and Filtration Business
Thermo Fisher Scientific has announced that the company has entered into a definitive agreement with Solventum to acquire its Purification & Filtration business for approximately $4.1 billion in cash.
FDA authorises COVID/influenza POC multiplex molecular test
Aptitude Medical Systems has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its next-gen molecular Metrix COVID-19/Flu multiplex test.
NHS Chief to stand down at end of March
Amanda Pritchard has formally notified the NHS England Board of her decision to stand down as Chief Executive at the end of this financial year.
Spanish partnership for bioMérieux
Spanish hospital group Vall d’Hebron has entered into a new strategic research partnership with bioMérieux. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.
Alpha Laboratories celebrates 50 years
Alpha Laboratories (Eastleigh, UK) is celebrating its 50th anniversary this year, marking half a century of commitment to supporting clinicians, scientists, and patients across the globe.
Roche unveils novel sequencing by expansion technology
Roche has unveiled its proprietary, sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative sensor module, offers ultra-rapid, high-throughput sequencing that is both flexible and scalable for a broad range of applications.
New research into Ebola antibodies could lead to improved therapeutics
New research led by scientists at California’s La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.
Warnings of increased mpox transmission
International researchers have warned that the ongoing mpox outbreak in the Democratic Republic of the Congo (DRC) has the potential to spread across borders more rapidly. The mpox virus has mutated, and the new variant, clade 1b, has become more infectious.
Latest Issues
Launch Diagnostics provides complete pathology solutions with a comprehensive portfolio of high-quality diagnostic reagents and instrumentation from world leading manufacturers to the Health Services of the United Kingdom. Our associated companies also provide solutions to France, Belgium, and Luxemburg through Launch Diagnostics SAS, to the...
Run 15 Variant Classification and Clinical Impact of Variability - webinar
Online
16 September, 2025
GenQA at ESCV 2025
Thessaloniki Concert Hall
17 September, 2025
International nomenclature for genomics for complex numerical and structural abnormalities - webinar
Online
18 September, 2025
IBMS Congress
The International Convention Centre (ICC), Birmingham
22-25 September, 2025
Diagnostics North East Conference 2025
The Catalyst, Newcastle
3 October